Source: United States House of Representatives – Congressman David Schweikert (AZ-06)
October 13, 2020
WASHINGTON, DC – Today, Congressman David Schweikert (AZ-06) released the following statement applauding the National Institute of Allergy and Infectious Diseases (NIAID) for taking action towards funding the Coccidioidomycosis Collaborative Research Centers (CCRC) program, aimed to provide extended research for the improved diagnosis, treatment and prevention of Valley Fever.
“I am pleased to see NIAID taking the next steps towards such a prominent problem we face here in Arizona, by funding $6 million in Fiscal Year 2022 to these research teams needed for information and future cures for Valley Fever,” said Congressman Schweikert. “Too many individuals are infected by this terrible disease, and face life-long health problems. By funding this program we will take the next step in helping our brothers and sisters whose lives have been forever changed by Valley Fever.”
Recently, Congressmen David Schweikert (AZ-06) and Kevin McCarthy (CA-23), led a letter to National Institutes of Health (NIH) Director Dr. Francis Collins, and National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci, in support of proposed efforts to better understand Coccidioidomycosis. Following the letter, NIAID issued a formal funding opportunity announcement to establish Valley Fever research centers with the intent of committing $6M in FY22.
To read the full letter click HERE.
To read the grant announcement, click HERE.